Page last updated: 2024-10-25

clioquinol and Metabolic Diseases

clioquinol has been researched along with Metabolic Diseases in 1 studies

Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.

Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colarizi, A1
Giardini, O1
Bacchetta, V1
Signoretti, A1
Castro, M1

Other Studies

1 other study available for clioquinol and Metabolic Diseases

ArticleYear
[Acrodermatitis enteropathica. Diagnostic and pathogenetic considerations on a clinical case in a newborn infant].
    Minerva pediatrica, 1974, Apr-21, Volume: 26, Issue:14

    Topics: Acrodermatitis; Anti-Bacterial Agents; Clioquinol; Dehydration; Diarrhea, Infantile; Diet Therapy; F

1974